Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1

The poor survival rate of pancreatic cancer is still a major challenge for the clinicians and their patients. In this study, we evaluated the efficacy of metformin, an inhibitor of oxidative phosphorylation, in combination with LW6, which impairs malate dehydrogenase 2 activities, in treating pancre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xianbin, Liu, Peng, Shang, Yuru, Kerndl, Hagen, Kumstel, Simone, Gong, Peng, Vollmar, Brigitte, Zechner, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930432/
https://www.ncbi.nlm.nih.gov/pubmed/31897243
http://dx.doi.org/10.7150/jca.33029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930432/
https://www.ncbi.nlm.nih.gov/pubmed/31897243
http://dx.doi.org/10.7150/jca.33029

Ejemplares similares